Skip to main navigation Skip to search Skip to main content

Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: A prospective study

  • L W Foster
  • , L. McLellan
  • , L. Rybicki
  • , J. Dabney
  • , E. Copelan
  • , Brian Bolwell
  • Taussig Cancer Center
  • Cleveland Clinic Foundation

Research output: Contribution to journalArticlepeer-review

38 Scopus citations

Abstract

This prospective study validates the finding from retrospective research that having an inpatient lay care-partner (CP) is associated with better survival following allogeneic BMT. Compared with patients without a CP (n=76), patients with a CP (n=88) have significantly better OS (P=0.017) and relapse-free survival (RFS) (P=0.020). Four-year and median survivals were 42% and 36 months among patients with CPs, compared with 26% and 10 months among those without CPs. Four-year survival and median RFS were 39% and 25 months among those with CPs, compared with 23% and 7 months among those without CPs. Further, better survival and RFS were associated with CP visit duration of >3 h per day (P=0.005 and P=0.007, respectively) and with CP frequency of visits >75% of inpatient days (P=0.004 and P=0.010, respectively). A CP support program should encourage not only presence of a CP but also duration and frequency of CP visits associated with better patient survival. © 2013 Macmillan Publishers Limited All rights reserved.
Original languageEnglish
Pages (from-to)671-677
Number of pages7
JournalBone Marrow Transplantation
Volume48
Issue number5
DOIs
StatePublished - May 1 2013

Keywords

  • allogeneic BMT
  • lay care-partner support
  • patient survival

Cite this